The Swedish BioFINDER - Primary Care Study

Recruiting Observational Study
Mild Dementia Mild Cognitive Impairment SCD Alzheimer Disease Lewy Body Disease Frontotemporal Degeneration Vascular Dementia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Study type
Observational
Participants needed
1,200 (estimated)
Sponsor
Skane University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The overall aim of the study is to improve the diagnostic accuracy of AD and cognitive impairment in primary care settings to ensure better care and treatment as well as facilitate correct referrals to specialized memory clinics. The investigators will strive to recruit diverse and representative populations of patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI) and m…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. The patient seeks medical help because of cognitive symptoms experienced by the patient and/or informant OR The general practitioner suspects a progressive neurodegenerative disorder including, but not limited to, Alzheimer's disease, Lewy body disease, frontotemporal lobar d…
Contacts

Sebastian Palmqvist, MD, PhD

+46-40-331000

Sebastian.Palmqvist@med.lu.se

CONTACT

Erik Stomrud, MD, PhD

+46 40 33 10 00

erik.stomrud@med.lu.se

CONTACT